相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Update on Potential Drugs for the Treatment of Diabetic Kidney Disease
Brian Shepler et al.
CLINICAL THERAPEUTICS (2012)
Disruption of the association of integrin-associated protein (IAP) with tyrosine phosphatase non-receptor type substrate-1 (SHPS)-1 inhibits pathophysiological changes in retinal endothelial function in a rat model of diabetes
L. A. Maile et al.
DIABETOLOGIA (2012)
Dysregulated Nephrin in Diabetic Nephropathy of Type 2 Diabetes: A Cross Sectional Study
Belinda Jim et al.
PLOS ONE (2012)
Vitronectin Increases Vascular Permeability by Promoting VE-Cadherin Internalization at Cell Junctions
Rong Li et al.
PLOS ONE (2012)
The Endothelium in Diabetic Nephropathy
Andrew Advani et al.
SEMINARS IN NEPHROLOGY (2012)
CaMK4 Gene Deletion Induces Hypertension
Gaetano Santulli et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2012)
Endothelial Dysfunction and Diabetes: Effects on Angiogenesis, Vascular Remodeling, and Wound Healing
Gopi Krishna Kolluru et al.
INTERNATIONAL JOURNAL OF VASCULAR MEDICINE (2012)
Urinary Markers of Glomerular Injury in Diabetic Nephropathy
Abraham Cohen-Bucay et al.
INTERNATIONAL JOURNAL OF NEPHROLOGY (2012)
Podocytopathy in Diabetes: A Metabolic and Endocrine Disorder
Ana Diez-Sampedro et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2011)
Blockade of TSP1-Dependent TGF-β Activity Reduces Renal Injury and Proteinuria in a Murine Model of Diabetic Nephropathy
Ailing Lu et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
A Glimpse of Various Pathogenetic Mechanisms of Diabetic Nephropathy
Yashpal S. Kanwar et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
New approaches to the treatment of nephropathy in diabetes
Merlin C. Thomas et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
Evaluation of the anti-angiogenic properties of the new selective αVβ3 integrin antagonist RGDechiHCit
Gaetano Santulli et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Endothelial dysfunction as a potential contributor in diabetic nephropathy
Takahiko Nakagawa et al.
NATURE REVIEWS NEPHROLOGY (2011)
Amelioration of renal alterations in obese type 2 diabetic mice by vasohibin-1, a negative feedback regulator of angiogenesis
Daisuke Saito et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Potential New Therapeutic Agents for Diabetic Kidney Disease
Faruk Turgut et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Mechanisms of Diabetic Nephropathy - Old Buddies and Newcomers Part 1
P. P. Nawroth et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2010)
Critical role for osteopontin in diabetic nephropathy
Susanne B. Nicholas et al.
KIDNEY INTERNATIONAL (2010)
A Monoclonal Antibody Against αVβ3 Integrin Inhibits Development of Atherosclerotic Lesions in Diabetic Pigs
Laura A. Maile et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Vasohibin-1, a Negative Feedback Regulator of Angiogenesis, Ameliorates Renal Alterations in a Mouse Model of Diabetic Nephropathy
Tatsuyo Nasu et al.
DIABETES (2009)
Abnormal Angiogenesis in Diabetic Nephropathy
Takahiko Nakagawa et al.
DIABETES (2009)
Overproduction of phosphoprotein enriched in diabetes (PED) induces mesangial expansion and upregulates protein kinase C-β activity and TGF-β1 expression
F. Oriente et al.
DIABETOLOGIA (2009)
BMP Signaling and Podocyte Markers Are Decreased in Human Diabetic Nephropathy in Association With CTGF Overexpression
Tamara Turk et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2009)
Mouse Models of Diabetic Nephropathy
Frank C. Brosius et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Modification of kidney barrier function by the urokinase receptor
Changli Wei et al.
NATURE MEDICINE (2008)
Oxidative stress-mediated mesangial cell proliferation requires RAC-1/Reactive oxygen species production and β4 integrin expression
Patrizia Dentelli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Regulation of IGF-I signaling in retinal endothelial cells by Hyperglycemia
Emily C. Miller et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
Hyperglycemia alters the responsiveness of smooth muscle cells to insulin-like growth factor-I
Laura A. Maile et al.
ENDOCRINOLOGY (2007)
Therapeutic potential of angiostatin in diabetic nephropathy
Sarah X. Zhang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Insulin-like growth factor-I signaling in smooth muscle cells is regulated by ligand binding to the 177CYDMKTTC184 sequence of the β3-subunit of αVβ3
LA Maile et al.
MOLECULAR ENDOCRINOLOGY (2006)
Mechanism of perturbation of integrin-mediated cell-matrix interactions by reactive carbonyl compounds and its implication for pathogenesis of diabetic nephropathy
VK Pedchenko et al.
DIABETES (2005)
Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model
K Ichinose et al.
DIABETES (2005)
Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy
Y Yamamoto et al.
DIABETES (2004)
Expression of constitutively active cGMP-dependent protein kinase prevents glucose stimulation of thrombospondin 1 expression and TGF-β activity
SX Wang et al.
DIABETES (2003)
分享论文
